BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 8242639)

  • 1. Serum and plasma M(r) 92,000 progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma.
    Nakajima M; Welch DR; Wynn DM; Tsuruo T; Nicolson GL
    Cancer Res; 1993 Dec; 53(23):5802-7. PubMed ID: 8242639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials.
    Nakajima M; Welch DR; Belloni PN; Nicolson GL
    Cancer Res; 1987 Sep; 47(18):4869-76. PubMed ID: 3621180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells.
    Nakajima M; Lotan D; Baig MM; Carralero RM; Wood WR; Hendrix MJ; Lotan R
    Cancer Res; 1989 Apr; 49(7):1698-706. PubMed ID: 2538232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
    Fridman R; Toth M; Peña D; Mobashery S
    Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
    Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
    Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth of rat mammary adenocarcinoma cells in semisolid clonogenic medium not correlated with spontaneous metastatic behavior: heterogeneity in the metastatic, antigenic, enzymatic, and drug sensitivity properties of cells from different sized colonies.
    Nicolson GL; Lembo TM; Welch DR
    Cancer Res; 1988 Jan; 48(2):399-404. PubMed ID: 2825974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential release of active proteinase inhibitors by two rat mammary adenocarcinoma variants possessing different metastatic potentials.
    Neri A; Bohoslawec O; Anderson TD; Tokes ZA
    Cancer Res; 1991 Feb; 51(4):1318-25. PubMed ID: 1997170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer.
    Endo K; Maehara Y; Baba H; Yamamoto M; Tomisaki S; Watanabe A; Kakeji Y; Sugimachi K
    Anticancer Res; 1997; 17(3C):2253-8. PubMed ID: 9216697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of the neutrophil calcium-binding protein, MRP-14, in metastasis-enhancing neutrophils.
    McGary CT; Pan YC; Michel H; Guntrum WD; Neri A; Welch DR
    Anticancer Res; 1997; 17(1A):1-6. PubMed ID: 9066623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexpression of cytokeratins characteristic for myoepithelial and luminal cell lineages in rat 13762NF mammary adenocarcinoma tumors and their spontaneous metastases.
    Lichtner RB; Julian JA; North SM; Glasser SR; Nicolson GL
    Cancer Res; 1991 Nov; 51(21):5943-50. PubMed ID: 1718590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors.
    Velasco G; Cal S; Merlos-Suárez A; Ferrando AA; Alvarez S; Nakano A; Arribas J; López-Otín C
    Cancer Res; 2000 Feb; 60(4):877-82. PubMed ID: 10706098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of matrix metalloproteinase genes in transformed rat cell lines of high and low metastatic potential.
    Sreenath T; Matrisian LM; Stetler-Stevenson W; Gattoni-Celli S; Pozzatti RO
    Cancer Res; 1992 Sep; 52(18):4942-7. PubMed ID: 1325287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies against cell-surface antigens of the metastatic rat 13762NF mammary adenocarcinoma and their cross-reactivity with human breast carcinomas.
    North SM; Steck PA; Nicolson GL
    Cancer Res; 1986 Dec; 46(12 Pt 1):6393-9. PubMed ID: 3779654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of highly metastatic rat MTLn2 mammary adenocarcinoma cell variants using in vitro growth response to transferrin.
    Cavanaugh PG; Nicolson GL
    J Cell Physiol; 1998 Jan; 174(1):48-57. PubMed ID: 9397155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma.
    Hayasaka A; Suzuki N; Fujimoto N; Iwama S; Fukuyama E; Kanda Y; Saisho H
    Hepatology; 1996 Nov; 24(5):1058-62. PubMed ID: 8903375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
    Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for paracrine regulation of experimental metastasis in 13762NF rat mammary adenocarcinoma cell clones.
    Welch DR; Aeed PA; Earhart RH; McClure SA
    Anticancer Res; 1994; 14(5A):1743-51. PubMed ID: 7847807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and some properties of a lung-derived growth factor that differentially stimulates the growth of tumor cells metastatic to the lung.
    Cavanaugh PG; Nicolson GL
    Cancer Res; 1989 Jul; 49(14):3928-33. PubMed ID: 2544264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis and necrosis occurring during different stages of primary and metastatic tumor growth of a rat mammary adenocarcinoma.
    Matsuda H; Strebel FR; Kaneko T; Stephens LC; Danhauser LL; Jenkins GN; Toyota N; Bull JM
    Anticancer Res; 1996; 16(3A):1117-21. PubMed ID: 8702222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo.
    Rabbani SA; Gladu J
    Cancer Res; 2002 Apr; 62(8):2390-7. PubMed ID: 11956102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.